These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12888133)

  • 1. Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies.
    Wienbergen H; Gitt AK; Schiele R; Juenger C; Heer T; Meisenzahl C; Limbourg P; Bossaller C; Senges J;
    Am J Cardiol; 2003 Aug; 92(3):285-8. PubMed ID: 12888133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
    Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial.
    Saw J; Steinhubl SR; Berger PB; Kereiakes DJ; Serebruany VL; Brennan D; Topol EJ;
    Circulation; 2003 Aug; 108(8):921-4. PubMed ID: 12925453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antiplatelet effect of clopidogrel is not attenuated by statin treatment in patients with acute coronary syndromes undergone coronary stenting].
    Han YL; Li CY; Li Y; Kang J; Yan CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Sep; 35(9):788-92. PubMed ID: 18070466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.
    Park Y; Jeong YH; Tantry US; Ahn JH; Kwon TJ; Park JR; Hwang SJ; Gho EH; Bliden KP; Kwak CH; Hwang JY; Kim S; Gurbel PA
    Eur Heart J; 2012 Sep; 33(17):2151-62. PubMed ID: 22507978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
    Wenaweser P; Windecker S; Billinger M; Cook S; Togni M; Meier B; Haeberli A; Hess OM
    Am J Cardiol; 2007 Feb; 99(3):353-6. PubMed ID: 17261397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin for reduction of myocardial damage during angioplasty trials.
    Nusca A; Melfi R; Patti G; Di Sciascio G
    J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):709-11. PubMed ID: 20815110
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.
    Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P;
    J Intern Med; 2009 Nov; 266(5):457-66. PubMed ID: 19549094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of statins on clopidogrel platelet inhibition in patients with acute coronary syndrome or stable angina].
    Shen J; Zhang RY; Zhang Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):807-11. PubMed ID: 19102862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent use of clopidogrel (Plavix) and atorvasatin (Lipitor) is contraindicated.
    Chetty N; Naran NH; Munster M
    S Afr Med J; 2006 Apr; 96(4):264. PubMed ID: 16670787
    [No Abstract]   [Full Text] [Related]  

  • 12. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
    Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
    Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: the prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation).
    Poyet R; Cuisset T; Frere C; Quilici J; Gaborit B; Moro PJ; Camoin L; Morange PE; Bonnet JL; Alessi MC
    Thromb Res; 2010 Nov; 126(5):e397-9. PubMed ID: 20825983
    [No Abstract]   [Full Text] [Related]  

  • 14. Atorvastatin for acute coronary syndromes.
    Wierzbicki AS; Mikhaildis DP; Reynolds TR
    JAMA; 2001 Aug; 286(5):532-3; author reply 533-5. PubMed ID: 11476649
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis.
    Lotfi A; Schweiger MJ; Giugliano GR; Murphy SA; Cannon CP;
    Am Heart J; 2008 May; 155(5):954-8. PubMed ID: 18440347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine statin treatment after acute coronary syndromes?
    Acevedo M; Sprecher DL; Lauer MS; Francis G
    Am Heart J; 2002 Jun; 143(6):940-2. PubMed ID: 12075242
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.
    Trenk D; Hochholzer W; Frundi D; Stratz C; Valina CM; Bestehorn HP; Büttner HJ; Neumann FJ
    Thromb Haemost; 2008 Jan; 99(1):174-81. PubMed ID: 18217151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of statins on the antiplatelet effect of clopidogrel and on cardiovascular outcome in patients after coronary intervention].
    Zürn CS; Geisler T; Paterok M; Gawaz M
    Dtsch Med Wochenschr; 2008 Apr; 133(16):817-22. PubMed ID: 18398789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of low vs moderate dose of atorvastatin in clopidogrel resistance after coronary stenting in Korean patients with acute coronary syndrome.
    Hong SJ; Park JY; Kim KA; Ahn CM; Park JS; Kim YH; Shim WJ; Park SM; Lim DS
    Circ J; 2009 Jun; 73(6):1111-8. PubMed ID: 19372620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential statin-clopidogrel interaction requires more study.
    Williams D; Ford I; Hawksworth G
    Circulation; 2004 Aug; 110(6):e68; author reply e68. PubMed ID: 15302814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.